One such cytokine is IL-1β, a ligand for the IL-1R that produces in vivo and in vitro carcinogenic changes downstream of MAPK and NF-κB that promotes immunosuppression, angiogenesis, and the invasion of cancer [3,82,83]. This evidence concerns the gene NFKB1 and cancer.